Showing results (1331-1340 of 2,747) with videos related to
Sort By:
Pageof 275
Clinical and Experimental Nephrology|May 25, 2026
Diabetic peripheral neuropathy as an independent predictor of renal function decline in type 2 diabetes: a propensity score-matched retrospective cohort study using DPN-Check®Hiroyuki Ito, Manami Yamamoto, Hideyuki Inoue, et al.Clinical and Experimental Nephrology|April 25, 2026
Association of osteoporosis treatment with risk of fracture, cardiovascular disease, and all-cause mortality in patients on maintenance dialysis: a retrospective database study using real-world data in JapanYasuo Imanishi, Kanae Takahashi, Hisako Yoshida, et al.Clinical and Experimental Nephrology|November 27, 2012
The effects of iron on FGF23-mediated Ca-P metabolism in CKD patientsSerpil Muge Deger, Yasemin Erten, Ozge Tugce Pasaoglu, et al.Clinical and Experimental Nephrology|December 1, 2016
Control of phosphate balance by the kidney and intestineIchiro Kaneko, Sawako Tatsumi, Hiroko Segawa, et al.Clinical and Experimental Nephrology|August 30, 2022
Association of the nutritional risk index for Japanese hemodialysis with mortality and dietary nutritional intake in patients undergoing hemodialysis during long-term hospitalizationKou Kitabayashi, Suguru Yamamoto, Ichiei NaritaClinical and Experimental Nephrology|June 8, 2026
Rituximab vs. cyclophosphamide in treatment-naive IMN: efficacy and renal protection in early renal impairmentQi Yu, Qin Yang, Shan Wu, et al.Clinical and Experimental Nephrology|May 26, 2026
Effects of processed low-protein brown rice on patients with chronic kidney diseaseKeika Adachi, Marie Yasuda, Makiko Ida, et al.Clinical and Experimental Nephrology|June 2, 2026
Relationships of high mean corpuscular volume, low total iron binding capacity and protein-energy wasting in patients on maintenance hemodialysisMisa Ikeda-Taniguchi, Keiichi Hirao, Keigo Shibagaki, et al.Clinical and Experimental Nephrology|May 8, 2019
Gap acidosis except lactic acidosis develops and progresses during chronic kidney disease stage G5Masayuki TanemotoClinical and Experimental Nephrology|September 14, 2012
Autophagy: a novel therapeutic target for kidney diseasesShinji Kume, Takashi Uzu, Hiroshi Maegawa, et al.Pageof 275